Langni Liu

机构：The University of Texas Health Science Center at Houston · ORCID：0000-0001-8069-6711

发表论文 26 篇 · 总被引 330 次 · h-index 10

代表论文

• Angiotensin-(1–7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways (2015 · Experimental Cell Research · 被引 83)
• Keratinocyte-derived microvesicle particles mediate ultraviolet B radiation–induced systemic immunosuppression (2021 · Journal of Clinical Investigation · 被引 59)
• Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells (2018 · International Journal of Molecular Sciences · 被引 26)
• Thermal Burn Injury Generates Bioactive Microvesicles: Evidence for a Novel Transport Mechanism for the Lipid Mediator Platelet-Activating Factor (PAF) That Involves Subcellular Particles and the PAF Receptor (2020 · The Journal of Immunology · 被引 25)
• UVB‐generated Microvesicle Particles: A Novel Pathway by Which a Skin‐specific Stimulus Could Exert Systemic Effects (2016 · Photochemistry and Photobiology · 被引 24)
• C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b/Akt pathway (2020 · Journal of Translational Medicine · 被引 20)